Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Feb;51(1):48-53.
doi: 10.3325/cmj.2010.51.48.

Association of nephrolithiasis and gene for glucose transporter type 9 (SLC2A9): study of 145 patients

Affiliations

Association of nephrolithiasis and gene for glucose transporter type 9 (SLC2A9): study of 145 patients

Ozren Polasek et al. Croat Med J. 2010 Feb.

Abstract

Aim: To investigate the association of nephrolithiasis and solute carrier family 2, facilitated glucose transporter, member 9 (SLC2A9), also known as glucose transporter type 9, Glut9.

Methods: A total of 145 participants were recruited in the period April-October 2008 from the Department of Mineral Research of the Medical School Osijek, Osijek, Croatia; 58 (40%) had confirmed nephrolithiasis and 87 (60%) were asymptomatic. Four single nucleotide polymorphisms (SNP) from the SLC2A9 gene were genotyped in both groups (rs733175, rs6449213, rs1014290, and rs737267).

Results: There was a weak but significant association of all 4 SNPs and nephrolithiasis (P=0.029 for rs733175; P=0.006 for rs6449213; P=0.020 for rs1014290, and P=0.011 for rs737267). Logistic regression in an age- and sex-adjusted model suggested that genotype C/T for rs6449213 had odds ratio for nephrolithiasis of 2.89 (95% confidence interval 1.13-7.40). This SNP explained a total of 4.4% of nephrolithiasis variance.

Conclusion: Development of nephrolithiasis may be associated with SLC2A9 gene. Further studies are needed to clarify the role of SLC2A9 gene as a link between uric acid and nephrolithiasis.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Achilles W, Dekanic D, Burk M, Schalk C, Tucak A, Karner I. Crystal growth of calcium oxalate in urine of stone-formers and normal controls. Urol Res. 1991;19:159–64. doi: 10.1007/BF00303742. - DOI - PubMed
    1. Sayer JA. The genetics of nephrolithiasis. Nephron Exp Nephrol. 2008;110:e37–43. doi: 10.1159/000151730. - DOI - PubMed
    1. Mesaric S, Radonic M, Tucak A. The pattern of urinary-tract stone disease in Croatia. Urol Res. 1988;16:192.
    1. Brikowski TH, Lotan Y, Pearle MS. Climate-related increase in the prevalence of urolithiasis in the United States. Proc Natl Acad Sci U S A. 2008;105:9841–6. doi: 10.1073/pnas.0709652105. - DOI - PMC - PubMed
    1. Tucak A, Mesaric S, Galic J, Vancura K. An analysis of 265 samples of calcium-oxalate concrements in the uropoetic tract in patients of the Osijek region. Urol Res. 1988;16:201.

Publication types

Substances